Search

Your search keyword '"Onorato, GL"' showing total 32 results

Search Constraints

Start Over You searched for: Author "Onorato, GL" Remove constraint Author: "Onorato, GL"
32 results on '"Onorato, GL"'

Search Results

1. ARIA pharmacy 2018 'Allergic rhinitis care pathways for community pharmacy'

2. Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air ® App

3. Adherence to treatment in allergic rhinitis using mobile technology. the mask study

4. Geolocation with respect to personal privacy for the Allergy Diary app - a MASK study

5. ARIA Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

6. Differences in Reporting the Ragweed Pollen Season Using Google Trends across 15 Countries

7. CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report

8. Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA 2 LEN consensus.

9. [ARIA (Allergic Rhinitis and its Impact on Asthma) 2019. Treatments for allergic rhinitis - Italy.]

10. Digital Health Europe (DHE) Twinning on severe asthma-kick-off meeting report.

11. ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020).

12. COVID-19 pandemic: Practical considerations on the organization of an allergy clinic-An EAACI/ARIA Position Paper.

13. ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice.

14. Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study.

15. Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement.

16. Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement.

17. Interactions Between Air Pollution and Pollen Season for Rhinitis Using Mobile Technology: A MASK-POLLAR Study.

18. Mobile Technology in Allergic Rhinitis: Evolution in Management or Revolution in Health and Care?

19. Google Trends and pollen concentrations in allergy and airway diseases in France.

20. Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 2).

21. Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 1).

22. Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study.

23. ARIA pharmacy 2018 "Allergic rhinitis care pathways for community pharmacy": AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Santé) POLLAR (Impact of Air POLLution on Asthma and Rhinitis) GARD Demonstration project.

24. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma.

25. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology.

26. The Reference Site Collaborative Network of the European Innovation Partnership on Active and Healthy Ageing.

27. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence.

28. Treatment of allergic rhinitis using mobile technology with real-world data: The MASK observational pilot study.

29. Geolocation with respect to personal privacy for the Allergy Diary app - a MASK study.

30. Differences in Reporting the Ragweed Pollen Season Using Google Trends across 15 Countries.

31. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project).

32. CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report.

Catalog

Books, media, physical & digital resources